ALC:NYSE
Alcon AG
74,31Â US$
arrow_downward
-0,26%(-0,19) 1K
74,31Â US$
0,00% (0,00)
bedtimeYopilgandan keyin
Savdolar yopilgan: 20-noy, 16:00:05 (GMT-5) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoALC tikeri uchun statistika yaratilmoqda...
Ochish
74,16Â US$
Yuqori
75,04Â US$
Past
74,10Â US$
Bozor kapitali
31,15Â mlrd
Oʻrtacha hajm
2,43Â mln
Hajmi
3,42Â mln
52 haftalik eng yuqori
87,64Â US$
52 haftalik eng past
61,84Â US$
Beta
0,87
Muomaladagi aksiyalar
480,40Â mln
Xodimlar soni
25Â ming
Ochish
74,16Â US$
Yuqori
75,04Â US$
Past
74,10Â US$
Bozor kapitali
31,15Â mlrd
Oʻrtacha hajm
2,43Â mln
Hajmi
3,42Â mln
52 haftalik eng yuqori
87,64Â US$
52 haftalik eng past
61,84Â US$
Beta
0,87
Muomaladagi aksiyalar
480,40Â mln
Xodimlar soni
25Â ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
ad-hoc-news.de
·
23 soat oldin
Alcon stock: Pershing Square takes a $954 million stake
TradingView
·
1 kun oldin
Alcon Inc. Stock 12‑Month Price Target Raised to $86.4, Implies 16% Upside
Profil
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
Alcon AG haqida
CEODavid J. Endicott
Xodimlar soni25Â ming
Asos solingan1945
Bosh ofislarJeneva, Geneva, Shveytsariya
SektorHealth Care
Soha-
Veb-saytalcon.com